Abstract
Literature publications (up to September 2004) concerning the targeted intervention of organophosphorus synthons in mechanisms of the replicative cycle, and the therapeutic benefits resulting (of particular relevance to anticancer and antiviral therapeutics) are reviewed. DNA-cross-linking agents comprising established oxazaphosphorinanes such as cyclophosphamide, ifosfamide and trofosfamide, and the aziridine agent thiotepa are discussed along with recent developments in prodrugs of associated activated metabolites. Established and novel nucleoside phosphonates are described subsequently in relation to inhibition of viral and cellular DNA polymerases and reverse transcriptases, along with inhibition of nucleotide metabolising enzymes such as purine nucleoside phosphorylase, thymidine phosphorylase, inosine monophosphate dehydrogenase, S-adenosyl-L-homocysteine hydrolase, and ribonucleoside diphosphate reductase. In this context, the role of organophosphorus chemistry in the development of intracellular delivery systems for antiviral/anticancer nucleotides has been reviewed, as have therapeutic developments concerning the pyrophosphate mimetic foscarnet. Finally, the inhibition of virally-encoded proteases such as HIV-PR, HCMV-PR and HCV NS3/NS4A protease by substrate-mimetic organophosphorus synthons has been discussed along with the role of synthetic oligonucleotides in antisense therapies for a range of disease-states.
Keywords: Antiproliferative agents, nephrotoxicities, breast cancer xenograft models, Aziridines, DNA replication, CYP-450, Immunomodulation
Current Organic Chemistry
Title: Organophosphorus Chemistry: Therapeutic Intervention in Mechanisms of Viral and Cellular Replication
Volume: 9 Issue: 18
Author(s): Nick J. Wardle, S. W. A. Bligh and Harry R. Hudson
Affiliation:
Keywords: Antiproliferative agents, nephrotoxicities, breast cancer xenograft models, Aziridines, DNA replication, CYP-450, Immunomodulation
Abstract: Literature publications (up to September 2004) concerning the targeted intervention of organophosphorus synthons in mechanisms of the replicative cycle, and the therapeutic benefits resulting (of particular relevance to anticancer and antiviral therapeutics) are reviewed. DNA-cross-linking agents comprising established oxazaphosphorinanes such as cyclophosphamide, ifosfamide and trofosfamide, and the aziridine agent thiotepa are discussed along with recent developments in prodrugs of associated activated metabolites. Established and novel nucleoside phosphonates are described subsequently in relation to inhibition of viral and cellular DNA polymerases and reverse transcriptases, along with inhibition of nucleotide metabolising enzymes such as purine nucleoside phosphorylase, thymidine phosphorylase, inosine monophosphate dehydrogenase, S-adenosyl-L-homocysteine hydrolase, and ribonucleoside diphosphate reductase. In this context, the role of organophosphorus chemistry in the development of intracellular delivery systems for antiviral/anticancer nucleotides has been reviewed, as have therapeutic developments concerning the pyrophosphate mimetic foscarnet. Finally, the inhibition of virally-encoded proteases such as HIV-PR, HCMV-PR and HCV NS3/NS4A protease by substrate-mimetic organophosphorus synthons has been discussed along with the role of synthetic oligonucleotides in antisense therapies for a range of disease-states.
Export Options
About this article
Cite this article as:
Wardle J. Nick, Bligh W. A. S. and Hudson R. Harry, Organophosphorus Chemistry: Therapeutic Intervention in Mechanisms of Viral and Cellular Replication, Current Organic Chemistry 2005; 9 (18) . https://dx.doi.org/10.2174/138527205774913123
DOI https://dx.doi.org/10.2174/138527205774913123 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors
Current Pharmaceutical Design Axin PPI Networks: New Interacting Proteins and New Targets?
Current Topics in Medicinal Chemistry Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches
Current Pharmaceutical Biotechnology Azathioprine in Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry Cyclophosphamide: Time to Say Goodnight and Goodbye?
Current Rheumatology Reviews Diketoacid Inhibitors of HIV-1 Integrase: From L-708,906 to Raltegravir and Beyond
Current Medicinal Chemistry Aminophosphonate Metal Complexes of Biomedical Potential
Current Medicinal Chemistry Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Current Topics in Medicinal Chemistry Inhibition of DNA Polymerase λ Suppresses 12-O-Tetradecanoylphorbol- 13-Acetate-Induced Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Cellular and Humoral Responses following Minimally Invasive Surgery: Role of Reactive Oxygen Species
Current Metabolomics Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1
Anti-Cancer Agents in Medicinal Chemistry MDR Reversal by Deprenylated Tetracyclic and Hexacyclic Analogues of N-Acetylardeemin: Confirmation of the Ardeemin Pharmacophore
Letters in Drug Design & Discovery Metabolism and Distribution of Novel Tumor Targeting Drugs In Vivo
Current Drug Metabolism DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
Current Pharmacogenomics Modulation of Antibiotic Efflux in Bacteria
Current Medicinal Chemistry - Anti-Infective Agents Current Status of Epigenetics and Anticancer Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia
Current Cancer Therapy Reviews miRNAs in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications
Current Pharmaceutical Design The Novel Role for Lyn in Integrin Signaling in Human Disease
Current Signal Transduction Therapy Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy
Current Cancer Drug Targets